Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | R De Wit, GS. Kulkarni, EM. Uchio, LEM Krieger, JL. Boormans, M Roumiguie, EA. Singer, DF. Bajorin, AM. Kamat, P Grivas, HK Seo, H Nishiyama, BR. Konety, K Nam, E Kapadia, TL. Frenkl, AV Balar | ||||||||||||
Title | Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG): Updated follow-up from KEYNOTE-057. | ||||||||||||
|
|||||||||||||
URL | https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.4530 | ||||||||||||
Abstract Text | Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 4530-4530 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|